FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2561082020> ?p ?o ?g. }

• W2561082020 endingPage "427" @default.
• W2561082020 startingPage "420" @default.
• W2561082020 abstract "Background Nephrotic edema is considered refractory if it does not respond to maximum or near-maximum doses of loop diuretics. This condition can be treated with loop diuretics and thiazides. However, animal studies show that the simultaneous downregulation of pendrin with acetazolamide and inhibition of the sodium-chloride cotransporter with hydrochlorothiazide generates significant diuresis, and furosemide administration following a pendrin inhibitor potentiates furosemide’s diuretic effect. Therefore, we performed this study to compare the efficacy of acetazolamide and hydrochlorothiazide followed by furosemide versus furosemide and hydrochlorothiazide followed by furosemide for treatment of refractory nephrotic edema. Study Design Randomized, double-blind, 2-arm, parallel trial. Setting & Participants 20 patients with refractory nephrotic edema despite treatment with 80 mg of furosemide daily and creatinine clearance > 60 mL/min. Intervention Patients were randomly assigned to 2 groups: group 1 (n = 10) received 250 mg of acetazolamide and 50 mg of hydrochlorothiazide daily and group 2 (n = 10) received 40 mg of furosemide and 50 mg of hydrochlorothiazide daily for 1 week in phase 1. In phase 2, both groups received 40 mg of furosemide daily for 2 weeks. Outcomes The primary outcome was absolute change in weight before and at the end of each phase. Measurements Weight and 24-hour urine volume at baseline and the end of each phase. Results The mean weight decrease was of significantly larger magnitude in group 1 compared with group 2 at the end of phase 1 (−1.4 ± 0.52 [SD] vs −0.65 ± 0.41 kg; P = 0.001) and phase 2 (−1.6 ± 0.84 vs −0.5 ± 0.47 kg; P = 0.005). The increase in 24-hour urine volume was also significantly higher in group 1 at the end of phase 2. Limitations Small sample size, short follow-up duration, and lack of serum bicarbonate and chloride measurement. Conclusions Acetazolamide and hydrochlorothiazide followed by furosemide is more effective than furosemide and hydrochlorothiazide followed by furosemide for the treatment of refractory nephrotic edema. Nephrotic edema is considered refractory if it does not respond to maximum or near-maximum doses of loop diuretics. This condition can be treated with loop diuretics and thiazides. However, animal studies show that the simultaneous downregulation of pendrin with acetazolamide and inhibition of the sodium-chloride cotransporter with hydrochlorothiazide generates significant diuresis, and furosemide administration following a pendrin inhibitor potentiates furosemide’s diuretic effect. Therefore, we performed this study to compare the efficacy of acetazolamide and hydrochlorothiazide followed by furosemide versus furosemide and hydrochlorothiazide followed by furosemide for treatment of refractory nephrotic edema. Randomized, double-blind, 2-arm, parallel trial. 20 patients with refractory nephrotic edema despite treatment with 80 mg of furosemide daily and creatinine clearance > 60 mL/min. Patients were randomly assigned to 2 groups: group 1 (n = 10) received 250 mg of acetazolamide and 50 mg of hydrochlorothiazide daily and group 2 (n = 10) received 40 mg of furosemide and 50 mg of hydrochlorothiazide daily for 1 week in phase 1. In phase 2, both groups received 40 mg of furosemide daily for 2 weeks. The primary outcome was absolute change in weight before and at the end of each phase. Weight and 24-hour urine volume at baseline and the end of each phase. The mean weight decrease was of significantly larger magnitude in group 1 compared with group 2 at the end of phase 1 (−1.4 ± 0.52 [SD] vs −0.65 ± 0.41 kg; P = 0.001) and phase 2 (−1.6 ± 0.84 vs −0.5 ± 0.47 kg; P = 0.005). The increase in 24-hour urine volume was also significantly higher in group 1 at the end of phase 2. Small sample size, short follow-up duration, and lack of serum bicarbonate and chloride measurement. Acetazolamide and hydrochlorothiazide followed by furosemide is more effective than furosemide and hydrochlorothiazide followed by furosemide for the treatment of refractory nephrotic edema." @default.
• W2561082020 created "2017-01-06" @default.
• W2561082020 creator A5007539737 @default.
• W2561082020 creator A5014162557 @default.
• W2561082020 creator A5014579815 @default.
• W2561082020 creator A5020068411 @default.
• W2561082020 creator A5080684509 @default.
• W2561082020 date "2017-03-01" @default.
• W2561082020 modified "2023-10-02" @default.
• W2561082020 title "Acetazolamide and Hydrochlorothiazide Followed by Furosemide Versus Furosemide and Hydrochlorothiazide Followed by Furosemide for the Treatment of Adults With Nephrotic Edema: A Randomized Trial" @default.
• W2561082020 cites W1551781691 @default.
• W2561082020 cites W1589284809 @default.
• W2561082020 cites W1835369445 @default.
• W2561082020 cites W1963527725 @default.
• W2561082020 cites W1992879574 @default.
• W2561082020 cites W2021164093 @default.
• W2561082020 cites W2023519267 @default.
• W2561082020 cites W2026000539 @default.
• W2561082020 cites W2028662301 @default.
• W2561082020 cites W2046339602 @default.
• W2561082020 cites W2049436857 @default.
• W2561082020 cites W2052042346 @default.
• W2561082020 cites W2064143634 @default.
• W2561082020 cites W2089627708 @default.
• W2561082020 cites W2105712625 @default.
• W2561082020 cites W2117376136 @default.
• W2561082020 cites W2125105964 @default.
• W2561082020 cites W2154638149 @default.
• W2561082020 cites W2159467118 @default.
• W2561082020 cites W2188122003 @default.
• W2561082020 cites W2297942143 @default.
• W2561082020 cites W2345738618 @default.
• W2561082020 cites W2347182223 @default.
• W2561082020 cites W2398412573 @default.
• W2561082020 cites W4235615051 @default.
• W2561082020 doi "https://doi.org/10.1053/j.ajkd.2016.10.022" @default.
• W2561082020 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28043731" @default.
• W2561082020 hasPublicationYear "2017" @default.
• W2561082020 type Work @default.
• W2561082020 sameAs 2561082020 @default.
• W2561082020 citedByCount "11" @default.
• W2561082020 countsByYear W25610820202017 @default.
• W2561082020 countsByYear W25610820202019 @default.
• W2561082020 countsByYear W25610820202020 @default.
• W2561082020 countsByYear W25610820202022 @default.
• W2561082020 countsByYear W25610820202023 @default.
• W2561082020 crossrefType "journal-article" @default.
• W2561082020 hasAuthorship W2561082020A5007539737 @default.
• W2561082020 hasAuthorship W2561082020A5014162557 @default.
• W2561082020 hasAuthorship W2561082020A5014579815 @default.
• W2561082020 hasAuthorship W2561082020A5020068411 @default.
• W2561082020 hasAuthorship W2561082020A5080684509 @default.
• W2561082020 hasConcept C126322002 @default.
• W2561082020 hasConcept C126894567 @default.
• W2561082020 hasConcept C134018914 @default.
• W2561082020 hasConcept C159641895 @default.
• W2561082020 hasConcept C197934379 @default.
• W2561082020 hasConcept C2777405951 @default.
• W2561082020 hasConcept C2777482430 @default.
• W2561082020 hasConcept C2777955127 @default.
• W2561082020 hasConcept C2779547328 @default.
• W2561082020 hasConcept C2779918671 @default.
• W2561082020 hasConcept C2780361556 @default.
• W2561082020 hasConcept C2780886150 @default.
• W2561082020 hasConcept C2781117629 @default.
• W2561082020 hasConcept C71924100 @default.
• W2561082020 hasConcept C84393581 @default.
• W2561082020 hasConceptScore W2561082020C126322002 @default.
• W2561082020 hasConceptScore W2561082020C126894567 @default.
• W2561082020 hasConceptScore W2561082020C134018914 @default.
• W2561082020 hasConceptScore W2561082020C159641895 @default.
• W2561082020 hasConceptScore W2561082020C197934379 @default.
• W2561082020 hasConceptScore W2561082020C2777405951 @default.
• W2561082020 hasConceptScore W2561082020C2777482430 @default.
• W2561082020 hasConceptScore W2561082020C2777955127 @default.
• W2561082020 hasConceptScore W2561082020C2779547328 @default.
• W2561082020 hasConceptScore W2561082020C2779918671 @default.
• W2561082020 hasConceptScore W2561082020C2780361556 @default.
• W2561082020 hasConceptScore W2561082020C2780886150 @default.
• W2561082020 hasConceptScore W2561082020C2781117629 @default.
• W2561082020 hasConceptScore W2561082020C71924100 @default.
• W2561082020 hasConceptScore W2561082020C84393581 @default.
• W2561082020 hasIssue "3" @default.
• W2561082020 hasLocation W25610820201 @default.
• W2561082020 hasLocation W25610820202 @default.
• W2561082020 hasOpenAccess W2561082020 @default.
• W2561082020 hasPrimaryLocation W25610820201 @default.
• W2561082020 hasRelatedWork W1835369445 @default.
• W2561082020 hasRelatedWork W1999453559 @default.
• W2561082020 hasRelatedWork W2338578170 @default.
• W2561082020 hasRelatedWork W2413099252 @default.
• W2561082020 hasRelatedWork W2561082020 @default.
• W2561082020 hasRelatedWork W2758328078 @default.
• W2561082020 hasRelatedWork W2900946669 @default.
• W2561082020 hasRelatedWork W3111959595 @default.
• W2561082020 hasRelatedWork W3183333244 @default.
• W2561082020 hasRelatedWork W4249284316 @default.
• W2561082020 hasVolume "69" @default.

• next